Bailard’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,714
| Closed | -$242K | – | 704 |
|
|
2021
Q1 | $242K | Sell |
1,714
-1,800
| -51% | -$254K | 0.01% | 594 |
|
|
2020
Q4 | $457K | Buy |
3,514
+14
| +0.4% | +$1.82K | 0.02% | 347 |
|
|
2020
Q3 | $510K | Hold |
3,500
| – | – | 0.03% | 279 |
|
|
2020
Q2 | $518K | Hold |
3,500
| – | – | 0.03% | 267 |
|
|
2020
Q1 | $381K | Hold |
3,500
| – | – | 0.03% | 270 |
|
|
2019
Q4 | $403K | Hold |
3,500
| – | – | 0.02% | 355 |
|
|
2019
Q3 | $281K | Hold |
3,500
| – | – | 0.02% | 413 |
|
|
2019
Q2 | $254K | Hold |
3,500
| – | – | 0.02% | 453 |
|
|
2019
Q1 | $327K | Buy |
+3,500
| New | +$327K | 0.02% | 402 |
|
|
2018
Q1 | – | Sell |
-3,500
| Closed | -$445K | – | 470 |
|
|
2017
Q4 | $445K | Buy |
+3,500
| New | +$445K | 0.03% | 325 |
|
|
2013
Q3 | – | Sell |
-49,550
| Closed | -$1.54M | – | 216 |
|
|
2013
Q2 | $1.54M | Buy |
+49,550
| New | +$1.54M | 0.28% | 76 |
|